Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Epiphora After Radioactive Iodine Therapy in a Low-Risk Patient

Song, Heesung MD*; Jeong, Jinho MD; Ju Koh, Myeong MD

doi: 10.1097/RLU.0000000000000717
Interesting Images
Buy

It has been demonstrated that radioactive iodine therapy (RIT) is very useful for ablating remnant thyroid tissue or metastatic lesions after total thyroidectomy in well-differentiated thyroid cancer. Epiphora as a result of lacrimal drainage system obstruction is a rare complication of RIT. Previous studies have shown that most patients with epiphora after RIT are old ages, females, and with high cumulative radioactive iodine dose. Here, we report on a case of epiphora with low-risk factors including young ages, male, and 5.5-GBq (150-mCi) dose in the first RIT.

From the Departments of *Nuclear Medicine, †Ophthalmology, and ‡Radiology, Jeju National University School of Medicine, Jeju, Republic of Korea.

Received for publication September 16, 2014; revision accepted December 10, 2014.

Conflict of interest and sources of funding: none declared.

Reprints: Heesung Song, MD, Department of Nuclear Medicine, Jeju National University School of Medicine, Aran 13gil 15 (Ara-dong), Jeju city, Jeju, Republic of Korea. E-mail: heesung119@jejunu.ac.kr.

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.